Most notably, Kano and colleagues showed lower proliferation of astrocytes in the human brain (lower GFAP protein levels) as well as in iPSC-derived midbrain organoids (lower GFAP and S100B protein levels) in PD cases caused by mutation in the PRKN gene62. This evidence concerns the gene GFAP and Parkinson disease.